Vera Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Vera Therapeutics

09/05/2024 15:11

* Vera Therapeutics Inc  VERA.OQ  reported a quarterly
adjusted
loss of 56 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -80 cents.  The mean expectation of
eight analysts for the quarter was for a loss of 53 cents per
share. Wall Street expected results to range from -60 cents
to -46 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Vera Therapeutics Inc's reported EPS for the quarter was a
loss
of 56 cents​.
    * The company reported a quarterly loss of $28.38 million.
    * Vera Therapeutics Inc shares had risen by 4.2% this
quarter and
gained 192.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.2%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Vera
Therapeutics
Inc is $54.50 

This summary was machine generated from LSEG data May 9 at 02:10
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.53          -0.56          Missed
 Dec. 31 2023      -0.51          -0.60          Missed
 Sep. 30 2023      -0.53          -0.45          Beat
 Jun. 30 2023      -0.69          -0.46          Beat